Perhaps I don't understand the legal arguments here, but I "heard" (sorry if you're offended by this) that the other generic, amphaster, applied for a summary judgment which momenta argued against because the supreme court was going to hear Classen. I guess there was a recommendation from the solicitor general that classen not be heard by the court. that made mnta's argument against summary judgement moot, and the likelihood of this case being heard by the supreme court very low. i don't think anything definitive, but sounds like set back for mnta.
as far as bond, if other generic has case that sales were lost because of mnta's prelim injunction, doesn't that mean bond is at risk? thought mnta owned 100% of bond.
i bought mnta because i thought downside limited, but i didn't realize there is still financial risk if mnta loses case. please correct if i'm wrong here.